San Antonio · San Diego · San Francisco · San Jose · Seattle · Tampa · Tucson ... A clinical-stage biotechnology company focused on the discovery and ...
News
- AnaptysBio Authorizes $100 Billion Buyback Plan - San Diego Today
- SignaBlok Receives Orphan Drug Designation from FDA for TREM-1 inhibitor for ... - Bergen Record
SHREWSBURY, MA, UNITED STATES, March 26, 2026 /EINPresswire.com/ — SignaBlok, Inc., a preclinical stage biotechnology ... San Antonio Businesses Traffic ...
- Unity Biotechnology Faces Dissolution After Nasdaq Delisting - South San Francisco Today
Unity Biotechnology, Inc., a biotechnology company focused on ... San Antonio · San Diego · San Francisco · San Jose · Seattle · Tampa · Tucson ...
- Comparing Predictive Oncology and Check-Cap Biotech Firms - Eagan Today
San Antonio · San Diego · San Francisco · San Jose · Seattle · Tampa · Tucson ... Comparing Predictive Oncology and Check-Cap Biotech Firms. Two small- ...
- Novartis to Acquire Excellergy in $2 Billion Deal - San Francisco Today
San Antonio · San Diego · San Francisco · San Jose · Seattle · Tampa · Tucson ... A San Francisco-based biotech firm that is being acquired by Novartis.